Cheung G
Department of Pharmacy Services, Hartford Hospital.
Conn Med. 1990 Jul;54(7):392-3.
Omeprazole is the first acid-pump inhibitor. With its unique mechanism of action, it represents a new class of drugs in treatment of GERD, reflux esophagitis, and hypersecretory conditions. Overall, its adverse effects are mild and transient and found to be well-tolerated. Thus, omeprazole will serve as an important new agent in the management of some gastrointestinal disorders.
奥美拉唑是首个酸泵抑制剂。凭借其独特的作用机制，它代表了一类用于治疗胃食管反流病、反流性食管炎及分泌过多状况的新型药物。总体而言，其不良反应轻微且短暂，耐受性良好。因此，奥美拉唑将成为治疗某些胃肠道疾病的一种重要新药。
